As of January 2025, Gufic Biosciences has a market cap of $520.21M. This makes Gufic Biosciences the world's 11072th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $378.25M | 1.50% |
2023 | $372.65M | 39.74% |
2022 | $266.67M | -4.69% |
2021 | $279.80M | 102.99% |
2020 | $137.84M | 93.79% |
2019 | $71.13M | -35.37% |
2018 | $110.05M | -26.27% |
2017 | $149.26M | 138.25% |
2016 | $62.65M | -3.18% |
2015 | $64.71M | 259.15% |
2014 | $18.02M | 148.78% |
2013 | $7.24M | -17.45% |
2012 | $8.77M | 52.04% |
2011 | $5.77M | -25.19% |
2010 | $7.71M | -36.71% |
2009 | $12.19M | 152.44% |
2008 | $4.83M | -82.99% |
2007 | $28.38M | 119.09% |
2006 | $12.95M | -45.41% |
2005 | $23.73M | -44.18% |
2004 | $42.51M | - |